Global Vascular Access Devices Market to Showcase One-Digit Growth, Says RNCOS in New Report Available at MarketPublishers.com
21 Nov 2016 • by Natalie Aster
LONDON – The incidence of diseases is on the rise, thus igniting the need for hospitalization. Many patients that are hospitalized get vascular access treatment.
The global market for vascular access devices is set to grow at a CAGR of slightly over 5.95% over the period 2016-2022. The growing acceptance of vascular products in the marketplace, technological advancements and an increasing burden of the kidney diseases are some of major drivers of the global market.
There are some restraints, as well. And a lack of skilled professionals is one of major restraints. Some of major trends in this marketplace comprise: the rising demand for PU-based catheters, an increase in strategic alliances in the market space, and more.
Peripheral devices are forecast to lead the marketplace in terms of product types. Yet, central vascular access devices are set to be the swiftest growing segment.
Medication administration represents the most common application in terms of the devices’ application. But hemodialysis monitoring makes up one of the promising segments.
When it comes to a route of administration, the largest share in the marketplace belongs to intravenous routes. North America is the most prominent player globally, with APAC being the fastest growing market.
Teleflex Medical, Smiths Medical and C.R. Bard are some of leading companies across the globe.
New research report “Global Vascular Access Devices Outlook 2022” elaborated by RNCOS E-Services Pvt. Ltd. offers a comprehensive guide to the worldwide market for vascular access devices. The study delves deep into dynamics of this marketplace.
It analyses the world’s market on the basis of products, insertion routes, applications and end-users. The report explores regional marketplaces, such as North America, APAC, Europe, and more.
The research study comprises detailed profiles of top companies (some of them are already mentioned above). Future outlook through 2022 is on hand in the report, too.
More new studies by RNCOS are available at its page.